212 related articles for article (PubMed ID: 35853537)
21. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
Liu B; Li J; Zheng M; Ge J; Li J; Yu P
Life Sci; 2017 Nov; 188():87-95. PubMed ID: 28866101
[TBL] [Abstract][Full Text] [Related]
22. SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway.
Li F; Wang J; Zhu Y; Liu L; Feng W; Shi W; Wang Q; Zhang Q; Chai L; Li M
Cell Physiol Biochem; 2018; 51(1):487-500. PubMed ID: 30453304
[TBL] [Abstract][Full Text] [Related]
23. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
24. MiR-376b-3p functions as a tumor suppressor by targeting KLF15 in non-small cell lung cancer.
Liu XW; Zhang CC; Zhang T
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9480-9486. PubMed ID: 33015790
[TBL] [Abstract][Full Text] [Related]
25. miR-16-5p regulates aerobic glycolysis and tumorigenesis of NSCLC cells via LDH-A/lactate/NF-κB signaling.
Arora S; Singh P; Tabassum G; Dohare R; Syed MA
Life Sci; 2022 Sep; 304():120722. PubMed ID: 35714705
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6621-6628. PubMed ID: 31378904
[TBL] [Abstract][Full Text] [Related]
27. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1.
Cao XZ; Bin H; Zang ZN
Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451
[TBL] [Abstract][Full Text] [Related]
28. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.
Hu C; Zou Y; Jing LL
J Biosci; 2020; 45():. PubMed ID: 32345774
[TBL] [Abstract][Full Text] [Related]
29. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
[TBL] [Abstract][Full Text] [Related]
30. SphK1-targeted miR-6784 inhibits functions of skin squamous cell carcinoma cells.
Gong ZH; Ji J; Yao J; Ji JF; Jiang Y; Gao G; Feng Z
Aging (Albany NY); 2021 Jan; 13(3):3726-3741. PubMed ID: 33465049
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
Dong Z; Liu H; Zhao G
Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
[No Abstract] [Full Text] [Related]
33. Translocation and activation of sphingosine kinase 1 by ceramide-1-phosphate.
Nishino S; Yamashita H; Tamori M; Mashimo M; Yamagata K; Nakamura H; Murayama T
J Cell Biochem; 2019 Apr; 120(4):5396-5408. PubMed ID: 30444039
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
35. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.
Kohno M; Momoi M; Oo ML; Paik JH; Lee YM; Venkataraman K; Ai Y; Ristimaki AP; Fyrst H; Sano H; Rosenberg D; Saba JD; Proia RL; Hla T
Mol Cell Biol; 2006 Oct; 26(19):7211-23. PubMed ID: 16980623
[TBL] [Abstract][Full Text] [Related]
36. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
Zhao L; Bi M; Zhang H; Shi M
Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
[No Abstract] [Full Text] [Related]
38. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.
Ruckhäberle E; Rody A; Engels K; Gaetje R; von Minckwitz G; Schiffmann S; Grösch S; Geisslinger G; Holtrich U; Karn T; Kaufmann M
Breast Cancer Res Treat; 2008 Nov; 112(1):41-52. PubMed ID: 18058224
[TBL] [Abstract][Full Text] [Related]
39. microRNA-338-3p functions as a tumor suppressor in human non‑small‑cell lung carcinoma and targets Ras-related protein 14.
Sun J; Feng X; Gao S; Xiao Z
Mol Med Rep; 2015 Feb; 11(2):1400-6. PubMed ID: 25374067
[TBL] [Abstract][Full Text] [Related]
40. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
